We are live on ! Find out more
NSPR icon

InspireMD

12 hedge funds and large institutions have $461K invested in InspireMD in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

71% more funds holding

Funds holding: 712 (+5)

0.02% more ownership

Funds ownership: 0%0.02% (+0.02%)

43% less capital invested

Capital invested by funds: $815K → $461K (-$354K)

Holders
12
Holders Change
+5
Holders Change %
+71.43%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
2
Reduced
Closed
5
Calls
Puts
Net Calls
Net Calls Change

NSPR Hedge Fund Activity: Q1 2018 in Review

12 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q1 2018, worth a combined $461K — down 43% from $815K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NSPR positions and 5 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, adding an estimated $551K. The largest seller was Anson Funds Management, exiting entirely with an estimated $85K sold.

  • 12 institutional investors held InspireMD (NSPR) as of Q1 2018, up from 7 in Q4 2017.
  • Funds reported $461K of InspireMD stock for Q1 2018, down 43% quarter-over-quarter.
  • 10 funds opened new InspireMD positions in Q1 2018 and 5 closed out, a net change of +5 holders.
  • The largest InspireMD buyer in Q1 2018 was Sabby Management, an estimated $551K added.
  • The largest InspireMD seller in Q1 2018 was Anson Funds Management, an estimated $85K sold.

Based on aggregated 13F filings for Q1 2018.